信德集團(0242.HK)全年盈利9.62億港元 增長267%
格隆匯3月25日丨信德集團(0242.HK)公佈,截至去年底止全年股東應占盈利9.62億港元,按年增長2.67倍,每股盈利31.9仙,不派末期息。就投資物業產生的未變現公平價值變動作出調整後,去年盈利10.52億港元,按年跌3.4%。期內,收益48.3億港元,按年增長15.26%。年內銷售橫琴綜合發展項目、澳門的濠尚,和新加坡的柏皓及蘭心居的收益入賬,令部門錄得溢利18.54億港元,比去年同期下降25%。集團表示,因所有海路口岸關閉,令客船服務停擺超過兩年,於去年,信德中旅船務投資有限公司錄得嚴重的分擔虧損3億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.